CureVac (CVAC) Earnings Date, Estimates & Call Transcripts

$3.72

+0.08 (+2.20%)

(As of 07/26/2024 ET)

Upcoming Earnings Date: Aug. 15Estimated
Actual EPS (May. 23): -$0.34 Missed By -$0.12
Consensus EPS (May. 23): -$0.22

CVAC Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

CVAC Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Ad Unstoppable Prosperity

“Generational Bull Run” Incoming

LIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 special FREE Gifts during the event.

You can find out what they are by clicking here now.

CureVac Analyst EPS Estimates

Quarter	Number of Estimates	Low Estimate	High Estimate	Average Estimate
Q1 2024	1	($0.14)	($0.14)	($0.14)
Q2 2024	1	($0.26)	($0.26)	($0.26)
Q3 2024	1	$1.65	$1.65	$1.65
Q4 2024	1	($0.28)	($0.28)	($0.28)
FY 2024	4	$0.97	$0.97	$0.97

CVAC Earnings Date and Information

CureVac last announced its earnings results on May 23rd, 2024. The reported ($0.34) EPS for the quarter, missing analysts' consensus estimates of ($0.22) by $0.12. The firm had revenue of $13.43 million for the quarter, compared to analysts' expectations of $14.51 million. CureVac has generated ($1.33) earnings per share over the last year (($1.33) diluted earnings per share). Earnings for CureVac are expected to decrease in the coming year, from $0.07 to ($0.49) per share. CureVac has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, August 15th, 2024 based off prior year's report dates.

CureVac Earnings History by Quarter

Time Frame

Start Date

End Date

Export to Excel

Date	Quarter	Consensus Estimate	Reported EPS	Beat/Miss	GAAP EPS	Revenue Estimate	Actual Revenue
8/15/2024 (Estimated)	-	-	-	-	-	-	-
5/23/2024	Q1 2024	($0.22)	($0.34)	($0.12)	($0.34)	$14.51 million	$13.43 million
4/24/2024	Q4 2023	-	($0.42)	($0.42)	($0.42)	-	$24.30 million
11/14/2023	Q3 2023	($0.26)	($0.24)	+$0.02	($0.24)	$15.01 million	$17.94 million
8/17/2023	Q2 2023	($0.28)	($0.33)	($0.05)	($0.33)	$14.89 million	$8.25 million
5/30/2023	Q1 2023	($0.29)	($0.29)	-	($0.29)	$16.45 million	$7.65 million
11/29/2020	Q2	($54.3660)	($0.24)	+$54.1260	-	-	-
Get the Latest News and Ratings for CVAC and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for CureVac and its competitors with MarketBeat's FREE daily newsletter.

CureVac Earnings - Frequently Asked Questions

When is CureVac's earnings date?: CureVac has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, August 15th, 2024 based off last year's report dates. Learn more on CVAC's earnings history.
Did CureVac beat their earnings estimates last quarter?: In the previous quarter, CureVac (NASDAQ:CVAC) missed the analysts' consensus estimate of ($0.22) by $0.12 with a reported earnings per share (EPS) of ($0.34). Learn more on analysts' earnings estimate vs. CVAC's actual earnings.
How much revenue does CureVac generate each year?: CureVac (NASDAQ:CVAC) has a recorded annual revenue of $59.00 million.
How much profit does CureVac generate each year?: CureVac (NASDAQ:CVAC) has a recorded net income of -$281.58 million. CVAC has generated -$1.33 earnings per share over the last four quarters.
What is CureVac's price-to-earnings ratio?: CureVac (NASDAQ:CVAC) has a forward price-to-earnings ratio of 53.14. The price/earnings-to-growth ratio is 1.88.
What is CureVac's EPS forecast for next year?: CureVac's earnings are expected to decrease from $0.07 per share to ($0.49) per share in the next year.